�Bayer officials on Tuesday announced that the ship's company has filed a patent infringement lawsuit against Sandoz, the generic medication division of Novartis, related to the oral contraceptive YAZ, Reuters reports.
Bayer has U.S. patent protective covering for YAZ, a lower-dose version of the oral contraceptive Yasmin, until March 2009. Sandoz has filed an applications programme with FDA for favourable reception to grocery a generic version of the medication. A Bayer spokesperson declined to comment on the details of the lawsuit.
Yasmin, YAZ and Yasminelle, a related product, had planetary sales of 1.04 billion euros, or around 1.6 billion dollars, last year (Reuters, 8/5).
Reprinted with tolerant permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for e-mail delivery hither. The Daily Women's Health Policy Report is a free robert William Service of the National Partnership for Women & Families, published by The Advisory Board Company.
� 2008 The Advisory Board Company. All rights reserved.
More info
